Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes

Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes

Myasthenia gravis (MG), an autoimmune neuromuscular disorder, may be a risk factor for severe COVID-19. We conducted an observational retrospective study with 15 consecutive adult MG patients admitted with COVID-19 at four hospitals in São Paulo, Brazil. Most patients with MG hospitalized for COVID-...

Full description

Bibliographic Details
Main Authors: Antonio E. Camelo-Filho, André M. S. Silva, Eduardo P. Estephan, Antônio A. Zambon, Rodrigo H. Mendonça, Paulo V. S. Souza, Wladimir B. V. R. Pinto, Acary S. B. Oliveira, Iron Dangoni-Filho, Ana F. P. Pouza, Berenice C. O. Valerio, Edmar Zanoteli
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Neurology
Subjects:
Myasthenia Gravis
COVID-19
SARS-CoV-2
neuromuscular disorders
immunosuppression
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.01053/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.01053/full

Similar Items